Origimm Biotechnology

ProVaDis: Protection-based Vaccine Discovery

ORIGIMM “OPENS ITS DOORS” TO INVESTORS AND INITIATES FUNDRAISING, NOVEMBER 2015

To celebrate our continuous success in both research and business development, we invited our existing shareholders and interested new investors to our annual Open House event. We presented to them our major achievements and our plan for the future. The event was also considered as the kick-off for our next fundraising round.